CN1185961A - Capsule for apoplexy - Google Patents

Capsule for apoplexy Download PDF

Info

Publication number
CN1185961A
CN1185961A CN96118838A CN96118838A CN1185961A CN 1185961 A CN1185961 A CN 1185961A CN 96118838 A CN96118838 A CN 96118838A CN 96118838 A CN96118838 A CN 96118838A CN 1185961 A CN1185961 A CN 1185961A
Authority
CN
China
Prior art keywords
radix
rhizoma
processed
apoplexy
hirudo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN96118838A
Other languages
Chinese (zh)
Other versions
CN1056296C (en
Inventor
郭贵江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96118838A priority Critical patent/CN1056296C/en
Publication of CN1185961A publication Critical patent/CN1185961A/en
Application granted granted Critical
Publication of CN1056296C publication Critical patent/CN1056296C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese patent medicine in the form of capsules for preventing and curing apoplexy is prepared from 31 Chinese-medicinal materials such as astragalus root, white atractylodes rhizome, Chinese angelica root, wolfberry fruit, alismatis rhizome, etc. through baking part of raw materials at 50-60 deg. C for 4-6 hrs, grinding others, mixing, 80-mesh sieving and loading into capsules.

Description

Capsule for apoplexy
The present invention relates to a kind of Chinese medicine Capsule for apoplexy that is used for the treatment of apoplexy.
Apoplexy is a kind of common frdquently encountered disease, and fatality rate is very high, for China's emphasis is captured one of disease.In wind-induced half body not tunnel, facial hemiparalysis, aphasis and because blood supply insufficiency, the brain atrophy that causes, alzheimer disease and the vasculitis etc. that cerebral arteriosclerosis causes are producing very serious harm to human body.Present state internal therapy apoplexy is that the compound Chinese medicinal preparation of cerebrovascular has tens of kinds, " NAOXUESHUAN PIAN " as the production of Lianyun Harbour pharmaceutical factory of traditional Chinese medicine, " HUATUO ZAIZAO WAN " that Qixing Pharmaceutical Factory of Guangzhou produces, " ZHONGFENG HUICHUN WAN " that the Xiu Tang pharmaceutical factory produces respected in Guangzhou, " NAOXINTONG JIAONANG " that Xianyang step-length drugmaker produces etc., the prescription main component of introducing from each tame disclosed description, medication biases toward more selects blood circulation promoting and blood stasis dispelling for use, soothing the channels and quicking the network vessels, suppressing the hyperactive liver and subsiding YANG and so on palliative is main, and the concerted application of drugs in the training unit of effecting a permanent cure is very few, especially on this foundation of acquired constitution of function of spleen and stomach regulating, more do not have and take into account, to such an extent as to often cause after taking medicine that spleen and stomach function is bad, can not continue to take.Also thorough not to the utmost with regard to it selecting on the medicine of taking stopgap measures, as in the disordered brain function treatment, not selecting the Chinese medicine that brain-care is directly arranged for use.The prolonged illness QI and blood is weak more had constipation, paralysed disease limbs that blood stasis is arranged more and suffers from limb swelling is arranged more, and sick just all has the brain swelling that does not wait degree, does not also see the agent of giving suitable diuresis etc., and it all has weak point with medicine composition.Though each tame medicine all has certain curative effect in treatment, in using, clinical practice realizes satisfaction unlike being introduced in its description.
The object of the present invention is to provide a kind of Chinese medicine Capsule for apoplexy that can effectively prevent and treat apoplexy.
The present invention realizes like this, it is according to the pathogenetic etiology and pathogenesis of apoplexy, the traditional Chinese medical science thinks that this disease mostly occurs over 40 years old, because of QI and blood declines few, deficiency of the liver and kindey, dysfunction of the spleen in transportation, visceral dysfunction, yin and yang imbalance and the qi depression to blood stasis that causes, give birth in the phlegm-damp, to such an extent as to the hepatic and renal YIN deficiency, liver-yang is high partially, the sun wind-transformation is moving, the disturbance QI and blood, bleeding resulting from adverse flow of QI holds up phlegm-damp fire upper punch in brain, illiteracy is closed the confused suddenly servant's syncope of key clearly, the horizontal string in meridians blocked then half body tunnel not of sering, apoplexy diseases such as aphasis, and feelings will changes, eating and drinking without temperance, overstrain, climate change mostly is its inducement.Thereby benefiting vital QI and blood has been proposed, nourishing the liver and kidney, invigorating spleen to remove dampness is with Zhi Qiben, blood circulation promoting and blood stasis dispelling, soothing the channels and quicking the network vessels, expelling wind to relieve convulsion, brain-care is to control its target principles of formulating prescriptions, so select the Chinese crude drug Radix Astragali for use, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Fructus Lycii, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Arisaema Cum Bile, Rhizoma Alismatis, Herba Taxilli, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Corydalis, Rhizoma Chuanxiong, Semen Persicae, Radix et Rhizoma Rhei (processed), Caulis Spatholobi, Flos Carthami, Olibanum (processed), Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Curcumae Longae, Hirudo, Herba Lycopodii, Bungarus Parvus, Rhizoma Acori Graminei, Radix Polygalae, Radix Scrophulariae, Radix Rehmanniae, Ramulus Uncariae Cum Uncis, Scorpio, Bombyx Batryticatus, Pheretima is batching, earlier above-mentioned batching is put into the cold drying case respectively to dry 4-6 hour dried disinfecting under 50 ℃-60 ℃ the temperature at interval, again with Olibanum (processed), Myrrha is ground into fine powder, with Scorpio, Bombyx Batryticatus, Pheretima, Bungarus Parvus, the Hirudo mixed powder is broken into fine powder, then all the other batch mixes are ground into fine powder, above-mentioned all batchings are sieved with 80 purposes sieve respectively, mix homogeneously then, incapsulate and obtain, the part by weight of its each batching is the Radix Astragali: yellow art: Radix Angelicae Sinensis: Fructus Lycii: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): Arisaema Cum Bile: Rhizoma Alismatis: Herba Taxilli: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Corydalis: Rhizoma Chuanxiong: Semen Persicae: Radix et Rhizoma Rhei (processed): Caulis Spatholobi: Flos Carthami: Olibanum (processed): Myrrha: Radix Salviae Miltiorrhizae: Rhizoma Curcumae Longae: Hirudo: Herba Lycopodii: Bungarus Parvus: Rhizoma Acori Graminei: Radix Polygalae: Radix Scrophulariae: Radix Rehmanniae: Ramulus Uncariae Cum Uncis: Scorpio: Bombyx Batryticatus: Pheretima=100: 12: 15: 10: 10: 10: 12: 15: 12: 10: 15: 15: 10: 5: 15: 10: 10: 10: 30: 10: 10: 20: 5: 10: 10: 10: 10: 15: 10: 10: 15.
The invention has the advantages that it has given prominence to benefiting vital QI and blood when prescription, nourishing the liver and kidney, invigorating spleen to remove dampness, element culturing fixed folder, the medication that effects a permanent cure of Yin Yang balancing, as the Radix Astragali, Radix Angelicae Sinensis, the Radix Rehmanniae, Fructus Lycii, the Rhizoma Atractylodis Macrocephalae etc., also note having enlarged the medication taste that takes stopgap measures simultaneously, as Hirudo, Rhizoma Curcumae Longae, Caulis Spatholobi, Herba Lycopodii, Bungarus Parvus etc., with blood circulation promoting and blood stasis dispelling, the suppressing liver-wind to relieve spasm medicine, painful to reach releasing patient limb, the hardship of limb spasm, be of value to functional rehabilitation, the patient is the long-term bed deficiency of both QI and blood after being ill, constipation is arranged more, added Radix Et Rhizoma Rhei among the we, Semen Persicae rushes down dampness removing heat with loosening bowel to relieve constipation, the blood circulation and promoting silt effect is arranged again, and paralyzed limbs often has edema, and the brain swelling that does not wait degree is just all arranged, so added Rhizoma Alismatis in order to damp and hot, eliminated and suffer from limb edema and brain swelling.Disordered brain function do not wait the existence of degree be stroke patient condition of illness must be arranged, therefore selected Rhizoma Acori Graminei, Radix Polygalae for use with brain-care effect.It is main double its mark of controlling that the present invention has given prominence to the key points to effect a permanent cure, and can effectively prevent and treat apoplexy.According to two First Five-Year Plan of nuclear industry Xianyang hospital from January, 1993---during the nineteen ninety-five December to the 825 routine apoplexy cases of being in hospital with Drug therapy of the present invention, it is evident in efficacy, does not have toxic and side effects, wherein cerebral infarction 559 examples, recovery rate is 47.05%, and total effective rate is 96.24%; Cerebral hemorrhage 266 examples, cure rate are 56.98%, and total effective rate is 92.81%.Simultaneously hemorheology, blood fat, superoxide dismutase (SOD) are detected all than having clear improvement before the treatment.The average hospital days cerebral infarction is 48.9 days, and cerebral hemorrhage is 43.9 days, and these indexs all are better than the requirement in " the sick quality control criterion of planting " (tentative draft) of Ministry of Health of the People's Republic of China in 1992 regulation.
The present invention is described in more detail with embodiment below:
The present invention selects the Chinese crude drug Radix Astragali for use, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Fructus Lycii, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Arisaema Cum Bile, Rhizoma Alismatis, Herba Taxilli, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Corydalis, Rhizoma Chuanxiong, Semen Persicae, Radix et Rhizoma Rhei (processed), Caulis Spatholobi, Flos Carthami, Olibanum (processed), Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Curcumae Longae, Hirudo, Herba Lycopodii, 1 of Bungarus Parvus, Rhizoma Acori Graminei, Radix Polygalae, Radix Scrophulariae, Radix Rehmanniae, Ramulus Uncariae Cum Uncis, Scorpio, Bombyx Batryticatus, Pheretima is batching, earlier above-mentioned batching is put into the cold drying case respectively with oven dry 4-6 hour dried disinfecting in gap under 50 ℃-60 ℃ the temperature, again with Olibanum (processed), Myrrha is ground into fine powder, with Scorpio, Bombyx Batryticatus, Pheretima, Bungarus Parvus, the Hirudo mixed powder is broken into fine powder, then all the other batch mixes are ground into fine powder, above-mentioned all batchings are sieved with 80 purposes sieve respectively, mix homogeneously then, every 0.4g packs a capsule into and obtains, and the part by weight of its each batching is the Radix Astragali: the Rhizoma Atractylodis Macrocephalae: Radix Angelicae Sinensis: Fructus Lycii: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): Arisaema Cum Bile: Rhizoma Alismatis: Herba Taxilli: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Corydalis: Rhizoma Chuanxiong: Semen Persicae: Radix et Rhizoma Rhei (processed): Caulis Spatholobi: Flos Carthami: Olibanum (processed): Myrrha: Radix Salviae Miltiorrhizae: Rhizoma Curcumae Longae: Hirudo: Herba Lycopodii: Bungarus Parvus: Rhizoma Acori Graminei: Radix Polygalae: Radix Scrophulariae: Radix Rehmanniae: Ramulus Uncariae Cum Uncis: Scorpio: Bombyx Batryticatus: Pheretima=100: 12: 15: 10: 10: 10: 12: 15: 12: 10: 15: 15: 10: 5: 15: 10: 10: 10: 30: 10: 10: 20: 5: 10: 10: 10: 10: 15: 10: 10: 15.When taking 3 times on the one, each 5-6 grain, be a course of treatment January.

Claims (1)

  1. A kind of Chinese medicine Capsule for apoplexy that is used for the treatment of apoplexy, it is characterized in that it selects the Chinese crude drug Radix Astragali for use, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Fructus Lycii, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Arisaema Cum Bile, Rhizoma Alismatis, Herba Taxilli, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Corydalis, Rhizoma Chuanxiong, Semen Persicae, Radix et Rhizoma Rhei (processed), Caulis Spatholobi, Flos Carthami, Olibanum (processed), Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Curcumae Longae, Hirudo, Herba Lycopodii, Bungarus Parvus, Rhizoma Acori Graminei, Radix Polygalae, Radix Scrophulariae, Radix Rehmanniae, Ramulus Uncariae Cum Uncis, Scorpio, Bombyx Batryticatus, Pheretima is batching, earlier above-mentioned batching is put into the cold drying case respectively with oven dry 4-6 hour dried disinfecting in gap under 50 ℃-60 ℃ the temperature, again with Olibanum (processed), Myrrha is ground into fine powder, with Scorpio, Bombyx Batryticatus, Pheretima, Bungarus Parvus, the Hirudo mixed powder is broken into fine powder, then all the other batch mixes are ground into fine powder, above-mentioned all batchings are sieved with 80 purposes sieve respectively, mix homogeneously then, incapsulate and obtain, the part by weight of its each batching is the Radix Astragali: the Rhizoma Atractylodis Macrocephalae: Radix Angelicae Sinensis: Fructus Lycii: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): Arisaema Cum Bile: Rhizoma Alismatis: Herba Taxilli: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Corydalis: Rhizoma Chuanxiong: Semen Persicae: Radix et Rhizoma Rhei (processed): Caulis Spatholobi: Flos Carthami: Olibanum (processed): Myrrha: Radix Salviae Miltiorrhizae: Rhizoma Curcumae Longae: Hirudo: Herba Lycopodii: Bungarus Parvus: Rhizoma Acori Graminei: Radix Polygalae: Radix Scrophulariae: Radix Rehmanniae: Ramulus Uncariae Cum Uncis: Scorpio: Bombyx Batryticatus: Pheretima=100: 12: 15: 10: 10: 10: 12: 15: 12: 10: 15: 15: 10: 5: 15: 10: 10: 10: 30: 10: 10: 20: 5: 10: 10: 10: 10: 15: 10: 10: 15.
CN96118838A 1996-12-26 1996-12-26 Capsule for apoplexy Expired - Fee Related CN1056296C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96118838A CN1056296C (en) 1996-12-26 1996-12-26 Capsule for apoplexy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96118838A CN1056296C (en) 1996-12-26 1996-12-26 Capsule for apoplexy

Publications (2)

Publication Number Publication Date
CN1185961A true CN1185961A (en) 1998-07-01
CN1056296C CN1056296C (en) 2000-09-13

Family

ID=5125395

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96118838A Expired - Fee Related CN1056296C (en) 1996-12-26 1996-12-26 Capsule for apoplexy

Country Status (1)

Country Link
CN (1) CN1056296C (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1098704C (en) * 1999-12-14 2003-01-15 王爱国 Preparation of hemiplegia treating capsule
CN1296087C (en) * 2004-10-15 2007-01-24 北京国仁堂医药科技发展有限公司 Compound capsule for treating apoplexy involving the meridians of wind phlegm stasis blockage syndrome type and preparation process thereof
CN1298338C (en) * 2005-07-21 2007-02-07 陈际华 Cardiovascular and cerebrovascular disease treating medicine
CN1319586C (en) * 2002-12-16 2007-06-06 闫位国 Medicinal composition for treating brain apoplexy
CN100415262C (en) * 2006-03-06 2008-09-03 赵刚 Medicine for treating cerebral infraction and its preparing method
CN102406769A (en) * 2011-07-11 2012-04-11 李保明 Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof
CN103463561A (en) * 2013-08-26 2013-12-25 荣成市科学技术情报研究所 Traditional Chinese medicine composition for treating cerebral thrombosis sequelae
CN107029106A (en) * 2017-04-05 2017-08-11 黄凤玲 Treat the medicine of apoplexy

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323683C (en) * 2005-09-05 2007-07-04 咸阳步长医药科技发展有限公司 Medicine composition for treating apoplexy and chest Bi-syndrome and its prepn

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1098704C (en) * 1999-12-14 2003-01-15 王爱国 Preparation of hemiplegia treating capsule
CN1319586C (en) * 2002-12-16 2007-06-06 闫位国 Medicinal composition for treating brain apoplexy
CN1296087C (en) * 2004-10-15 2007-01-24 北京国仁堂医药科技发展有限公司 Compound capsule for treating apoplexy involving the meridians of wind phlegm stasis blockage syndrome type and preparation process thereof
CN1298338C (en) * 2005-07-21 2007-02-07 陈际华 Cardiovascular and cerebrovascular disease treating medicine
CN100415262C (en) * 2006-03-06 2008-09-03 赵刚 Medicine for treating cerebral infraction and its preparing method
CN102406769A (en) * 2011-07-11 2012-04-11 李保明 Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof
CN102406769B (en) * 2011-07-11 2013-08-14 李保明 Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof
CN103463561A (en) * 2013-08-26 2013-12-25 荣成市科学技术情报研究所 Traditional Chinese medicine composition for treating cerebral thrombosis sequelae
CN103463561B (en) * 2013-08-26 2015-07-22 蒿崑 Traditional Chinese medicine composition for treating cerebral thrombosis sequelae
CN107029106A (en) * 2017-04-05 2017-08-11 黄凤玲 Treat the medicine of apoplexy

Also Published As

Publication number Publication date
CN1056296C (en) 2000-09-13

Similar Documents

Publication Publication Date Title
CN1191740A (en) Qihe fracture setting plaster with bone retaining liniment
CN1204523A (en) Prescription of dispelling wind and strengthening bone wine and preparation method
CN101085223A (en) Medicine for treating rheumatism and rheumatoid disease
CN101856447B (en) Capsule capable of clearing heat and purging fire
CN101229355B (en) Rheumatism soup
CN1056296C (en) Capsule for apoplexy
CN1278446A (en) Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
CN104338100A (en) Formula and preparation method of wind-dispelling and bone-strengthening wine
CN101690768B (en) Vein and artery relieving pills for impediment of sinew
CN102499972B (en) Pure traditional Chinese medicinal composition for treating endometritis of dairy cow by oral administration and preparation method thereof
CN1114206A (en) Plaster for curing dysmenorrhea
CN104027750A (en) Traditional Chinese medicament for treating conjunctivitis
CN101703710A (en) Chinese medicinal preparation for treating gout
CN102100826A (en) Chinese medicinal compound preparation for treating canine parvovirus enteritis and preparation method thereof
CN105535779A (en) Chinese medicinal composition for treating uremia
CN104173929A (en) Traditional Chinese medicine for treating ulcerative colitis
CN101239140A (en) Chinese medicine for treating psoriasis
CN1062176C (en) Oral liquid for curing cancer
CN100443114C (en) Antidiarrheal wiping powder and preparing process thereof
CN104225406A (en) Chinese medicine for treating lung abscess
CN103656463A (en) Traditional Chinese medicine for treating algomenorrhea
CN110227139A (en) A kind of Radix Salviae Miltiorrhizae strengthens muscles and bones particle and preparation method thereof
CN1093410C (en) Preparation method of medicinal liquor for treating rheumatic arthritis
CN103720972B (en) Traditional Chinese herbal medicinal ointment for treating hyperostosis and preparation method thereof
CN102743531B (en) Drug for treating cervical or lumbar diseases and preparation method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee